RXRX
#2084
Recursion Pharmaceuticals, Inc. - Class A Common Stock
3.4 0 USD
+0.01%
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
+1.21%
Monthly Change
+3.98%
6 month change
-26.88%
Year Change
-35.73%
Previous Close
3.3 4
Open
3.3 7
Low
3.3 3
High
3.4 0
Volume
1 046
Financials
- Market Capitalization 1.8 B
- Employee 600
- Founded 2013
- CEO Najat Khan
- Website www.recursion.com
- Headquarter Delaware, United States
- FIGI BBG00PQ4XJ45
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-2.65
Price to sales ratio
20.56
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 2071 |  ZYME Zymeworks Inc. - Common Stock | 24.66 USD | -1.12% | -7.36% | +5.84% | +39.01% | 1.80 B USD | ||
| 2072 |  AAPG Ascentage Pharma Group International - American Depository Shar | 19.24 USD | -1.94% | +4.96% | +13.11% | -23.04% | 1.80 B USD | ||
| 2095 |  IOVA Iovance Biotherapeutics, Inc. - Common Stock | 3.79 USD | -3.56% | -12.67% | -6.19% | +96.37% | 1.69 B USD | ||
| 2106 |  MPLT MapLight Therapeutics, Inc. - Common Stock | 37.91 USD | +3.66% | +3.18% | +35.54% | +99.53% | 1.72 B USD |
Frequently asked questions about Recursion Pharmaceuticals, Inc. - Class A Common Stock
What is the Recursion Pharmaceuticals, Inc. - Class A Common Stock stock price today?
The current price of Recursion Pharmaceuticals, Inc. - Class A Common Stock (RXRX) is 3.4. Over the past 24 hours, the stock has changed by +1.21%. Follow the RXRX chart for real-time price dynamics.
What is the stock ticker of Recursion Pharmaceuticals, Inc. - Class A Common Stock?
Recursion Pharmaceuticals, Inc. - Class A Common Stock trades under the ticker RXRX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Recursion Pharmaceuticals, Inc. - Class A Common Stock stock going up?
RXRX has changed by -9.81% over the last week, +3.98% over the last month, and -35.73% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Recursion Pharmaceuticals, Inc. - Class A Common Stock net income for the last quarter?
Recursion Pharmaceuticals, Inc. - Class A Common Stock reported net income of -117.5 M for the last quarter. The previous quarter showed -108.12 M, which means net income changed by -8.68%.
How many employees does Recursion Pharmaceuticals, Inc. - Class A Common Stock have?
As of the latest available data, Recursion Pharmaceuticals, Inc. - Class A Common Stock has 600 employees. Workforce size can provide additional context about the company's scale and operations.
What is Recursion Pharmaceuticals, Inc. - Class A Common Stock EBITDA?
Recursion Pharmaceuticals, Inc. - Class A Common Stock EBITDA is -108.83 M, and its EBITDA margin is -1 681.58%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Recursion Pharmaceuticals, Inc. - Class A Common Stock stock?
You can buy Recursion Pharmaceuticals, Inc. - Class A Common Stock (RXRX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Recursion Pharmaceuticals, Inc. - Class A Common Stock stock?
Investing in Recursion Pharmaceuticals, Inc. - Class A Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the RXRX chart and related analysis on metatrader.com as part of your research.